Correlation Between Caribou Biosciences and CalciMedica, Common
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and CalciMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and CalciMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and CalciMedica, Common Stock, you can compare the effects of market volatilities on Caribou Biosciences and CalciMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of CalciMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and CalciMedica, Common.
Diversification Opportunities for Caribou Biosciences and CalciMedica, Common
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Caribou and CalciMedica, is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and CalciMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CalciMedica, Common Stock and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with CalciMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CalciMedica, Common Stock has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and CalciMedica, Common go up and down completely randomly.
Pair Corralation between Caribou Biosciences and CalciMedica, Common
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 1.5 times more return on investment than CalciMedica, Common. However, Caribou Biosciences is 1.5 times more volatile than CalciMedica, Common Stock. It trades about -0.1 of its potential returns per unit of risk. CalciMedica, Common Stock is currently generating about -0.37 per unit of risk. If you would invest 202.00 in Caribou Biosciences on September 24, 2024 and sell it today you would lose (23.00) from holding Caribou Biosciences or give up 11.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
Caribou Biosciences vs. CalciMedica, Common Stock
Performance |
| Timeline |
| Caribou Biosciences |
| CalciMedica, Common Stock |
Caribou Biosciences and CalciMedica, Common Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and CalciMedica, Common
The main advantage of trading using opposite Caribou Biosciences and CalciMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, CalciMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CalciMedica, Common will offset losses from the drop in CalciMedica, Common's long position.| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
| CalciMedica, Common vs. Fate Therapeutics | CalciMedica, Common vs. Sana Biotechnology | CalciMedica, Common vs. Caribou Biosciences | CalciMedica, Common vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |